Boston Children's Hospital at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Boston Children's Hospital brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program covers ionizable lipid design for uses from infectious disease vaccines to muscle restoration in Duchenne muscular dystrophy. Its work also includes rapamycin nanoparticles carrying ponatinib that shrink venous malformations.

OrganizationAAPS 2026 PharmSci 360 Attendance
childrenshospital.org
Academic & healthcare
Pediatric hospital and research center affiliated with Harvard Medical School.
Talk
Tue Oct 27
9:30am–10:00am
Part of Symposium: Precision Delivery Frontiers: Redefining RNA and Advanced Therapeutics
Design, Structure-Activity Relations, and Unique Applications of the Ionizable Lipids: From Infectious Disease Vaccines to Intravenous Muscle Restoration in DMD
220-222
Formulation and Delivery
Talk
Tue Oct 27
3:45pm–4:00pm
Part of Rapid Fire: Emerging Drug Product and Delivery Technologies
Polymeric Rapamycin Nanoparticles Encapsulating Ponatinib Cause Regression of Venous Malformations
220-222
Formulation and Delivery

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Boston Children's Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction